Aerie Pharmaceuticals Profit Margin

The latest profit margin for AERI is -17.09% as of September 2022. That compares with -159.84% in the prior-year period — up 89.3% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Aerie Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, AERI's profit margin moved from -159.84% to -17.09% — a 89.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aerie Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, AERI currently prints -17.09% for profit margin, while the sector average sits near 13.89%. That is roughly 223.0% below the sector mean. Large gaps often invite a closer look at Aerie Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Aerie Pharmaceuticals converts resources into returns. At -17.09%, AERI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -159.84% in the prior-year period — up 89.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AERI's profit margin (-17.09%), review year-over-year change from -159.84%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.